To examine the independent association between five stages of activities of daily living (ADLs) and mortality after accounting for known diagnostic and sociodemographic risk factors. DESIGN: For five stages of ADLs (0 to IV), determined according to the severity and pattern of ADL limitations, unadjusted life expectancies and adjusted associations with mortality were estimated using a Cox proportional hazards regression model. SETTING: Community. PARTICIPANTS: Nine thousand four hundred forty-seven participants aged 70 and older from the second Longitudinal Study of Aging. MEASUREMENTS: One-, 5-, and 10-year survival and time to death. RESULTS: Median life expectancy was 10.6 years for participants with no ADL limitations and 6.5, 5.1, 3.8, and 1.6 years for those at ADL stages I, II, III, and IV, respectively. The sociodemographic-and diagnosticadjusted hazard of death at 1 year was five times as great at stage IV as at stage 0 (hazard ratio = 5.6, 95% confidence interval = 3.8-8.3). The associations between ADL stage and mortality declined over time but remained statistically significant at 5 and 10 years. CONCLUSION: ADL stage continued to explain mortality risk after adjusting for known risk factors including advanced age, stroke, and cancer. ADL stages might aid clinical care planning and policy as a powerful prognostic indicator particularly of short-term mortality, improving on current ADL measures by profiling activity limitations of relevance to determining community support needs. J Am Geriatr Soc 60:485-492, 2012.
D
ramatic increases in U.S. average life expectancy expose individuals to the cumulative effects of chronic illnesses and subsequent limitations in activities of daily living (ADLs). 1, 2 Although disability rates in the United States are declining faster than mortality, the most-severe ADL limitations are not declining, and health expenses accumulate with the onset of those limitations. 3, 4 Estimates from the Medicare Current Beneficiary Survey (MCBS) indicate that, in 2005, 18% of community-dwelling persons aged 65 and older had one or two ADL limitations, 5% had three or four, and 3% had five or six. 5 The number of older adults in the United States with three or more ADL limitations is expected to more than double by 2040, to between 4.5 million and 7.4 million. 5 Mortality risk increases with number of ADL limitations. 3, [6] [7] [8] Although greater numbers of limitations indicate greater severity of disability, the specific pattern of ADL limitations remains obscured because limitations in different patterns of activities can produce the same numeric count. Information about specific ADLs is essential for understanding the types of supportive care needed. For example, the care that people with problems toileting require differs from the care that those whose walking is limited require, so ADL stages were derived, with the recognition that, even for people with the same number of limitations, knowledge about the qualitative differences associated with alternative limitation patterns could substantially improve care planning.
ADL stages established for elderly persons living in the community express activity limitation 10 in a manner that profiles particular activities limited as well as severity. Stages define "thresholds of retained functioning" reflecting hierarchies consistent with theories of development, loss, and recovery and models and measures of disability. [10] [11] [12] [13] The thresholds specify the maximum difficulty that individuals can experience for each of six self-care activities and still be at a stage. A similar staging system predicts nursing home use, functional improvements, and 6-month survival in individuals undergoing rehabilitation. [14] [15] [16] [17] Using prospectively collected population-level data from the second Longitudinal Study of Aging (LSOA II), ADL stages were used to study survival in elderly community-dwelling people.
The primary hypothesis was that ADL stages would distinguish groups according to mortality risk in addition to sociodemographic circumstances and medical conditions known to be associated with poorer survival. [18] [19] [20] [21] [22] [23] Stagespecific survival rates might help in screening individuals and in projecting population care needs and prognosis with greater specificity.
METHODS
The institutional review board at the University of Pennsylvania approved this study.
Study population
Baseline data from LSOA II 24 were merged with the disability supplement follow-back of the 1994 National Health Interview Survey to enhance information about disability. The LSOA II studied 9,447 community-dwelling people aged 70 and older representative of the U.S. population. 25, 26 The overall response rate to the LSOA II was 87.4%. 26 Overviews of sample design and survey methods can be obtained through the Centers for Disease Control and Prevention website. 24 The updated LSOA II Linked Mortality Public-use File provided mortality follow-up from the date of the LSOA II baseline interview through December 31, 2006, 27 yielding follow-up ranging from 10 to 12 years depending on baseline interview date.
Of the 9,447 persons at LSOA II baseline, information on one or more ADL was missing for 130 (1.4%), and mortality data were missing for 45 (0.5%), leaving 9,272, or 98.1% of the original sample, for analysis. Although attempts were made to interview people themselves, close proxy respondents (living in the same household) provided information when targeted individuals could not be interviewed. Of the 9,272 individuals, 81.6% self-reported. Illness, sensory loss, cognitive impairment, communication difficulties, and other reasons were given as explanations for proxy use 24.1%, 26.3%, 27.9%, 11.0%, and 39.2% of the time, respectively, with some having multiple reasons.
Outcomes
All-cause mortality for up to 12 years after baseline interview was the outcome for analyses. Survival time was determined as the time between the baseline LSOA II interview and death. All Cox regression models were censored at death or the end of study (December 31, 2006) . Although all 12 years of available data were applied to estimate model parameters, mortality was reported at 1, 5, and 10 years.
ADL Stages
To assign ADL stages, respondents were asked questions about difficulties or inabilities eating, toileting (including getting to the toilet), dressing, transferring (getting in and out of bed or chairs), bathing, and walking, as detailed previously. 9 They rated limitations experienced when performing each activity as no difficulty (0), some difficulty (1), a lot of difficulty (2) , and unable (3). 28 Instructions for staging are shown in Table 1 . ADL stages were developed by observing item responses in the LSOA II baseline data using methods described previously. 9, 14, 29 Those methods organized patterns of item difficulty into thresholds associated with increasing complexity. 11, 12, 30 
Demographic and Diagnostic Factors
Age was categorized as 70 to 74, 75 to 79, 80 to 84, and 85 and older; race as white, black, and other; and marital status as married and nonmarried (e.g., single, widowed, divorced). Educational status was dichotomized into those who did and did not graduate from high school.
Diagnoses were according to self-or proxy-reported presence or absence of conditions diagnosed by a doctor, including chronic bronchitis or emphysema, asthma, diabetes mellitus, cancer of any kind, coronary artery disease (angina pectoris, myocardial infarction), other heart disease, hypertension, a history of stroke, arthritis, and osteoporosis. A major mental illness was considered present if the respondent reported schizophrenia, bipolar disorder, major depression, or paranoid disorder in the past 12 months.
The survey interviewer's decision to rely on proxy responses because of the sample person's "poor memory, senility, confusion, or Alzheimer's disease," was used to indicate the presence of cognitive impairment. Other reasons for proxy use, such as physical illness and disability, were not counted in the indicator of cognitive impairment.
Statistical Analysis
The LSOA II uses a multistage sample design. To obtain the correct point and variance estimates, clustering, sample weights, and stratification were accounted for in all analyses. Prevalence was calculated as weighted proportions. Unweighted sample sizes and weighted proportions were reported. Life expectancy for community-dwelling elderly adults was estimated according to ADL stage from a Kaplan-Meier plot. One-, 5-, and 10-year all-cause mortality was then reported according to ADL stage without adjusting for other factors. The 1-and 5-year time horizons were selected for their clinical relevance and the 10-year horizon for its longer-term policy implications.
To understand the independent effects of ADL stage on prognosis, the influence of the sociodemographic and diagnostic conditions known to be most associated with mortality were reduced. [18] [19] [20] [21] [22] [23] An indicator variable for all-cause mortality was defined to calculate the 1-, 5-, and 10-year survival rates for the overall sample and for each group defined by all covariates. Cox proportional hazards regression models were then used to estimate the associations between the covariates and mortality. ADL stage and all sociodemographic and available diagnostic factors identified from the literature were included. Because the models were hypothesis driven, an additional analysis was performed to confirm that no important statistical associations were missed for variables excluded from the model. All available variables not in the model (Table 2) were added, and backward selection was used to remove variables until the p-values for all variables were less than .05.
The proportional hazards assumption was checked by adding all time-varying interactions between all predictors and the natural logarithm-transformed time to the above models. Significance at P < .05 indicated violation of the proportional hazards assumption. When the proportional hazards assumption is violated, it is necessary to include interaction terms between these covariates and time to account for the nonconstant associations between them and mortality over the follow-up period. Considering the ease of interpretation and clinical relevance, hazard ratios (HRs) and 95% confidence intervals (95% CIs) were estimated for each discreet time point (1, 5, and 10 years) from models Is the individual able to eat and toilet without difficulty (0), dress and transfer with no more than some difficulty ( 1), and bathe and walk with no more than a lot of difficulty ( 2)? ADL-II = moderate difficulty: medium or fair ADL limitation Is the individual able to eat without difficulty (0); use the toilet, dress, and transfer with no more than a lot of difficulty ( 2); and possibly unable to bathe and walk ( 3)? ADL-III = severe difficulty: high or extreme ADL limitation Is the individual able to perform at least one ADL (eat, toilet, dress, transfer, bathe or walk) with or without assistance but does not meet the defined threshold for stage II? ADL-IV = complete difficulty: total ADL limitation Is the individual unable to eat, toilet, dress, transfer, bathe, and walk (all 3)? with these interaction terms. The HRs at 1, 5, and 10 years were also graphically displayed. All analyses used Stata 11 (Stata Corp., College Station, TX).
RESULTS
The mean age of participants at study initiation was 77.4; 59.8% were female. At baseline, 72.1% of study participants (weighted percentage) were at ADL-0 (no ADL limitations) 16 .1% at ADL-I (mild), 7.0% at ADL-II (moderate), 4.3% at ADL-III (severe), and 0.5% at ADL-IV (complete limitation).
Overall 1-, 5-, and 10-year survival was 95.6%, 73.3%, and 46.4%, respectively. Kaplan-Meier survivor curves indicated that participants at the least-limited ADL stages had the longest life expectancies (Figure 1 ). Those with no ADL limitations could be expected to live a median of 10.6 years, and median survival expectations for those at ADL-I, -II, -III, and -IV were 6.5, 5.1, 3.8, and 1.6 years, respectively. Survival rates for all available baseline covariates are shown in Table 2 . By the 10th year, survival ranged from 54.2% to 4.2% for stages ADL-0 to -IV. In comparison, survival at 10 years ranged from 45.2% for those with osteoporosis to 10.9% for All sample sizes were unweighted, and all rates (%) were weighted according to the complex sample design.
a Coronary heart disease, angina pectoris, heart attack, or myocardial infarction. those who required proxy use because of cognitive impairment. Table 3 shows unadjusted and sociodemographic-and diagnosis-adjusted HR estimates from the Cox regression models. The proportional hazards assumption of the Cox model was violated for stage, age, sex, stroke, cardiopulmonary, and cancer. For these covariates, HRs at 1, 5, and 10 years were shown for the adjusted models. For covariates not violating the assumption, the HR stayed constant over time. Results demonstrated that stage continued to explain risk of mortality after sociodemographic and diagnostic factors showing a strong upward gradient were adjusted for, with the hazard of death at 1 year increasing sharply with each higher stage. For example, being at ADL-I was associated with twice the risk of death at 1 year as ADL-0 (HR = 2.0, 95% CI = 1.7-2.3), whereas the risk of death at ADL-IV was more than five times greater than at ADL-0 (HR = 5.2, 95% CI = 3.4-8.1). Figure 2 demonstrates graphically the dynamic evolution of association over time for each stage relative to the no-limitation reference ADL-0 after adjusting for all other covariates in the statistical model (Figure 2A) . The slope was steepest for 1-year mortality, indicating that there was a decrement in the strength of association between stage and mortality risk over time. This decrement in association was strongest at the most-severe stages of disability. The plots show that, whereas at 1 year, the adjusted HR for ADL-IV compared with ADL-0 was very high (HR = 5.1, The table shows unadjusted and adjusted hazard ratios for 1-, 5-, and 10-year mortality applying a Cox regression model estimated using up to 12 years of follow-up data. ADL stages consist of hierarchical sets of thresholds defining the maximum amount of difficulty experienced for each of six ADLs, with higher numbers indicating greater limitation. They are ranked from mild (ADL-I) to complete limitation (ADL-IV).
RESULTS FROM COX REGRESSION MODELS
No change indicates that the hazard ratio (HR) was the same over time (i.e., the proportional hazards assumption was not violated). 95% CI = 3.1-8.1), the HR for mortality decreased strikingly at the 5-and 10-year time points and became insignificant when compared with those with no disability (i.e., the 95% CI included 1). Whereas at 1 year, the HRs for participants with less-severe disability (ADL-I, -II, and -III vs ADL-0) were smaller than for ADL-IV, the HRs of mortality decreased relatively less over 5 and 10 years and remained statistically significant when compared with those with no disability. The plots suggest that the effect of having an ADL limitation on the likelihood of mortality is much greater in the short term than long term. This effect was most prominent at ADL-IV. This means that those at stage IV who were unable to perform any ADLs who survived had lessmarked reductions in the likelihood of mortality over time than those in the reference group without any limitation in ADLs at baseline. Conversely, the contribution of advanced age strengthened over time ( Figure 2B) . The figure shows that the HRs of mortality were greater for those aged 85 and older than for those aged 70 to 74 (reference), meaning that the oldest old group had sharper increases in the likelihood of mortality over 1, 5, and 10 years than the younger groups, in whom the timerelated increases in mortality were less remarkable. When referenced to the youngest group, the oldest old group ( 85) had the sharpest time-related increases in mortality. Figure 2C illustrates that the survival disadvantage of being male is projected to decrease over time. Figure 2D indicates that, although the likelihood of mortality is projected to be greater for those with a previous stroke than for those without, the effects of cardiopulmonary disorders and cancer on mortality appears to attenuate over 1, 5, and 10 years.
Cognitive impairment, diabetes mellitus, chronic obstructive pulmonary disease (COPD) or emphysema, cancer, coronary artery disease, and stroke raised the hazard of 1-year mortality approximately 70%, 50%, 40%, 40%, 30%, and 10%, respectively, after adjusting for stage and sociodemographic characteristics. The hazard of mortality associated with cancer was no longer significant at 5 years. Additional analyses showed that, whereas all of the diagnoses originally hypothesized to be important risk factors elevated mortality risk, none of the diagnoses or other variables not originally hypothesized to be important significantly elevated risk.
DISCUSSION
Numerous staging systems in medicine express the severity and qualitative nature of pathology. The Tumor, Nodes, Metastases (TNM) system stimulated remarkable advances in oncology, with sustained declines in death rates attributed to risk factor reduction, better screening, and improved treatments. 31 It is hoped that disability staging, which characterizes patients according to function rather than pathology, will provide a similar stimulus to advancing disability management. Similar to TNM stages, results confirm that ADL stages are capable of distinguishing between groups of elderly community-dwelling people according to 1-, 5-, and 10-year survival. Anticipated depletion of the Medicare trust fund by 2024 32 as the number of baby boomers eligible for Medicare benefits swells, along with increasing prevalence of ADL limitations with advanced age, high associated costs of longterm care, and looming shortages of caregivers, 33 highlight the importance of being able to project trends in longevity in groups of older adults according to qualities of supportive care need. ADL stages simultaneously distinguish between groups of older adults according to the qualities of supportive care need and prognosis for survival.
The self-care tasks that people can be expected to perform become clear once an individual's stage is known. People at ADL-0 have no difficulty performing self-care tasks, and expected survival is high. Expected 1-, 5-, and 10-year survivals decrease directly with stage. People at ADL-I, with mild ADL limitations, can still perform all tasks but are expected to have considerable difficulty with bathing or walking. At ADL-II, people with moderate limitations can no longer be expected to perform these mostcomplex ADLs themselves. Those at ADL-III have severe disability patterns that fall outside the typical hierarchy. They experience difficulties with the usually easiest and most-fundamental self-care tasks of eating or using the toilet while retaining abilities to perform more challenging functions such as walking. At complete limitation ADL-IV, people are unable to perform any ADLs, all self-care ability is lost, care burden is maximized, and expected survival is lowest. The current study differs from previous reports on ADLs in which typical counts or summation methods characterize only severity, and the pattern of retained abilities is not transparent. 34, 35 The five ADL stages continue to distinguish groups in the population according to an ordered gradient of mortality after controlling for known risk factors. [18] [19] [20] [21] [22] [23] ADL stage remained strongly associated with death at all three time periods. Therefore, ADL stage might be applied to indicate mortality risk in addition to sociodemographic factors and diagnoses. These findings are consistent with numerous reports documenting strong associations between ADL limitations and mortality. 34, [36] [37] [38] [39] The study most similar to the current one was a prognostic index. 36 Because it included instrumental ADLs in addition to basic ADLs, it would be expected to produce a broader gradient. Two-year mortality was 5% for the lowest-risk group and 36% for the highest-risk group. 36 In the current study, 1-year mortality ranged from 2.5% for ADL-0 to 34.2% for ADL-IV.
Certain predictive factors become weaker or stronger with respect to effect on short-vs longer-term mortality. Differing time-related associations were particularly notable for people at differing ADL stages. The difference of the effect on likelihood of mortality between having complete ADL limitations and having no limitations was far greater in the short than the long term, suggesting that the few people at ADL-IV who survived 5 or 10 years were a unique subgroup who tended to continue to survive. Timerelated decrements in the association between stage and mortality also present at ADL-I, -II, and -III but are less remarkable than for ADL-IV, suggesting that ADL stage, like diagnoses such as cancer, better predict short-than long-term mortality. It is likely that this relates to the greater short-term mortality at higher stages of limitation and to the dynamic nature of function. 34, 35, 40 Intervening factors such as progressive cognitive decline will determine whether people can be expected to get better, stay the same, or get worse functionally. As stage transitions occur over time this could reduce the strength of associations with mortality, highlighting the need for periodic reassessment.
The current study applied self-reported diagnoses and functioning, which may differ from provider assessments. In addition, the patterns of mortality and survival found are generalizable only to community-dwelling elderly people; they do not necessarily reflect patterns in residents of institutions. Furthermore, observational studies are always vulnerable to unmeasured confounding factors. The data did not include a standard measure of cognition. Nevertheless, simple self-and proxy-reported diagnostic and functional status information have long been recognized as effective for stratifying community-dwelling persons according to varying mortality risk. 36, 41 Moreover, all questions were extensively field tested. 42 In addition, people already in institutions represent a different population with needs that are distinct from those still living in the community. Finally, many known characteristics most associated with mortality were adjusted for. [18] [19] [20] [21] [22] [23] Future work should address stage transitions and associations with other outcomes.
Stages might be applied to project 1-, 5-, and 10-year survival in the aging U.S. population. Constructed to reflect the profile of care needs of survivors, stages are easily determined, requiring only individuals' (or, when necessary, close proxy's) answers to simple questions about difficulties experienced in performing each activity. Application of stages to patient screening during outpatient visits or home care might capture early ADL problems while they are still treatable. Moreover, stratification according to stage could aid researchers and policy-makers in testing alternative disability management strategies and projecting needs for rehabilitative, supportive, and long-term care in the aging population. The effect of those strategies might be assessed relative to stage-specific survival. ADL stages, by placing a ceiling on the maximum amount of difficulty an individual can experience with each of the six ADLs along with estimated survival time, could prove beneficial in planning for the functional assistance and supportive aspects of care for the population.
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